Skip to main content

. 1979 May;66(1):126P.

Does DPI [(3,4-dihydroxy-phenylamino)-2-imidazoline] act at dopamine receptors on cortical neurones? [proceedings]

P Bevan, C M Bradshaw, R Y Pun, N T Slater, E Szabadi

PMCID: PMC2043798 PMID: 454921

126P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bevan P., Bradshaw C. M., Pun R. Y., Slater N. T., Szabadi E. Responses of single cortical neurones to noradrenaline and dopamine. Neuropharmacology. 1978 Aug;17(8):611–617. doi: 10.1016/0028-3908(78)90156-9. [DOI] [PubMed] [Google Scholar]
Bevan P., Bradshaw C. M., Szabadi E. The pharmacology of adrenergic neuronal responses in the cerebral cortex: evidence for excitatory alpha- and inhibitory beta-receptors. Br J Pharmacol. 1977 Apr;59(4):635–641. doi: 10.1111/j.1476-5381.1977.tb07732.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cools A. R., Boudier A. J., Rossum J. M. Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain. Eur J Pharmacol. 1976 Jun;37(2):283–293. doi: 10.1016/0014-2999(76)90036-4. [DOI] [PubMed] [Google Scholar]
Struyker Boudier H., Teppema L., Cools A., Van Rossum J. (3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition. J Pharm Pharmacol. 1975 Nov;27(11):882–883. doi: 10.1111/j.2042-7158.1975.tb10240.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (149.4 KB)

RESOURCES